Novavax, Inc. (NVAX) — Business segments and KPIs
Revenue by business segment and geography for Novavax, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Product | 685.04M | 50.0% |
| Nuvaxovid Sales | 625.18M | 45.6% |
| Supply Sales | 59.86M | 4.4% |
| Revenue by region | ||
| Rest of North America | 575.67M | 51.2% |
| UNITED STATES | 405.61M | 36.1% |
| Rest of the World | 126.46M | 11.3% |
| Europe | 15.74M | 1.4% |